PRESS RELEASE published on 03/21/2025 at 15:44, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.36% ownership of Direct Line Insurance Group plc securities as of 20 March 2025 Securities Form 8.3 The Vanguard Group Ownership Disclosure Direct Line Insurance Group Plc
BRIEF published on 03/18/2025 at 15:15, 1 year 5 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Position Des Titres Divulgation Des Intérêts Assurance Direct Line
BRIEF published on 03/18/2025 at 15:15, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Takeover Code Vanguard Group Interest Disclosure Direct Line Insurance Securities Position
PRESS RELEASE published on 03/18/2025 at 15:10, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses ownership stake of 5.36% in Direct Line Insurance Group plc as of 17 March 2025. Further disclosures regarding Aviva plc made Vanguard Group Ownership Stake Direct Line Insurance Disclosures Aviva Plc
BRIEF published on 03/17/2025 at 14:40, 1 year 5 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Transactions Boursières Divulgation Assurance Direct Line
BRIEF published on 03/17/2025 at 14:40, 1 year 5 months ago Vanguard Group Discloses Position in Direct Line Insurance Disclosure Takeover Code Vanguard Group Stock Transactions Direct Line Insurance
PRESS RELEASE published on 03/17/2025 at 14:35, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.37% stake in Direct Line Insurance Group plc as of 14 March 2025. Additional disclosures made for Aviva plc Vanguard Group Financial Disclosure Stake Disclosure Direct Line Insurance Group Plc Aviva Plc
BRIEF published on 03/14/2025 at 14:56, 1 year 5 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Form 8.3 Disclosure Vanguard Group Shareholding Direct Line Insurance
BRIEF published on 03/14/2025 at 14:56, 1 year 5 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Actionnariat Groupe Vanguard Divulgation Formulaire 8.3 Assurance Direct Line
PRESS RELEASE published on 03/14/2025 at 14:51, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group PLC The Vanguard Group, Inc. discloses a 5.37% interest in Direct Line Insurance Group PLC. Additional disclosure on cash offer involving Aviva plc The Vanguard Group Interest Disclosure Direct Line Insurance Group Plc Cash Offer Aviva Plc
Published on 09/10/2026 at 22:25, 12 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 45 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 40 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 55 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 30 minutes ago Availability of the 2026 Interim Financial Report
